A citation-based method for searching scientific literature

B S Fernandes, J Steiner, M Berk, M L Molendijk, A Gonzalez-Pinto, C W Turck, P Nardin, C-A Gonçalves. Mol Psychiatry 2015
Times Cited: 119







List of co-cited articles
973 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.
M J Green, S L Matheson, A Shepherd, C S Weickert, V J Carr. Mol Psychiatry 2011
265
35


Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.
Brisa S Fernandes, Marc L Molendijk, Cristiano A Köhler, Jair C Soares, Cláudio Manuel G S Leite, Rodrigo Machado-Vieira, Thamara L Ribeiro, Jéssica C Silva, Paulo M G Sales, João Quevedo,[...]. BMC Med 2015
119
22

BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
Maryna Polyakova, Katharina Stuke, Katharina Schuemberg, Karsten Mueller, Peter Schoenknecht, Matthias L Schroeter. J Affect Disord 2015
215
19

Transport of brain-derived neurotrophic factor across the blood-brain barrier.
W Pan, W A Banks, M B Fasold, J Bluth, A J Kastin. Neuropharmacology 1998
785
18


The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
16

Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.
Félicien Karege, Michèle Schwald, Mbaye Cisse. Neurosci Lett 2002
559
16

Blood BDNF concentrations reflect brain-tissue BDNF levels across species.
Anders B Klein, Rebecca Williamson, Martin A Santini, Christoffer Clemmensen, Anders Ettrup, Maribel Rios, Gitte M Knudsen, Susana Aznar. Int J Neuropsychopharmacol 2011
322
14

Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
Mei Hong Xiu, Li Hui, Yu Feng Dang, Tian De Hou, Chong Xi Zhang, You Lan Zheng, Da Chun Chen, Thomas R Kosten, Xiang Yang Zhang. Prog Neuropsychopharmacol Biol Psychiatry 2009
107
14

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.
Michael F Egan, Masami Kojima, Joseph H Callicott, Terry E Goldberg, Bhaskar S Kolachana, Alessandro Bertolino, Eugene Zaitsev, Bert Gold, David Goldman, Michael Dean,[...]. Cell 2003
14

The impact of age, weight and gender on BDNF levels in human platelets and plasma.
Marek Lommatzsch, Doerte Zingler, Katharina Schuhbaeck, Katharina Schloetcke, Christiana Zingler, Peter Schuff-Werner, Johann Christian Virchow. Neurobiol Aging 2005
510
13

Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes.
Da Chun Chen, Jing Wang, Bo Wang, Sheng Chang Yang, Chong Xi Zhang, You Lan Zheng, Yan Li Li, Ning Wang, Ke Bing Yang, Mei Hong Xiu,[...]. Psychopharmacology (Berl) 2009
99
13


Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
12

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
12

Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Sebnem Pirildar, Ali Saffet Gönül, Fatma Taneli, Fisun Akdeniz. Prog Neuropsychopharmacol Biol Psychiatry 2004
103
11

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology.
Anilkumar Pillai, Anvita Kale, Sadhana Joshi, Nilesh Naphade, M S V K Raju, Henry Nasrallah, Sahebarao P Mahadik. Int J Neuropsychopharmacol 2010
142
11

Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysis.
Anthony O Ahmed, Andrew M Mantini, Daniel J Fridberg, Peter F Buckley. Psychiatry Res 2015
55
20

Brain derived neurotropic factor in first-episode psychosis.
Peter F Buckley, Anilkumar Pillai, Denise Evans, Edna Stirewalt, Sahebarao Mahadik. Schizophr Res 2007
113
11


The role of BDNF in the pathophysiology and treatment of schizophrenia.
Gabriela Favalli, Jennifer Li, Paulo Belmonte-de-Abreu, Albert H C Wong, Zafiris Jeffrey Daskalakis. J Psychiatr Res 2012
106
10

Nicotine dependence and serum BDNF levels in male patients with schizophrenia.
Xiang Yang Zhang, Mei Hong Xiu, Da Chun Chen, Fu De Yang, Gui Ying Wu, Lin Lu, Therese A Kosten, Thomas R Kosten. Psychopharmacology (Berl) 2010
33
30


Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?
Sophia Vinogradov, Melissa Fisher, Christine Holland, Wendy Shelly, Owen Wolkowitz, Synthia H Mellon. Biol Psychiatry 2009
144
10

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
B S Fernandes, J Steiner, H-G Bernstein, S Dodd, J A Pasco, O M Dean, P Nardin, C-A Gonçalves, M Berk. Mol Psychiatry 2016
144
10


A neurotrophic model for stress-related mood disorders.
Ronald S Duman, Lisa M Monteggia. Biol Psychiatry 2006
10

Investigation of serum BDNF levels in drug-naive patients with schizophrenia.
E N Rizos, I Rontos, E Laskos, G Arsenis, P G Michalopoulou, D Vasilopoulos, R Gournellis, L Lykouras. Prog Neuropsychopharmacol Biol Psychiatry 2008
76
13


Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia.
Helton José Reis, Rodrigo Nicolato, Izabela Guimarães Barbosa, Paulo Henrique Teixeira do Prado, Marco Aurélio Romano-Silva, Antonio Lucio Teixeira. Neurosci Lett 2008
73
13

Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.
Aitor Palomino, Ainara Vallejo-Illarramendi, Ana González-Pinto, Ana Aldama, Cristina González-Gómez, Fernando Mosquera, Gixane González-García, Carlos Matute. Schizophr Res 2006
113
9

Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis.
Brisa Simões Fernandes, Clarissa Severino Gama, Keila Maria Ceresér, Lakshmi N Yatham, Gabriel Rodrigo Fries, Gabriela Colpo, David de Lucena, Mauricio Kunz, Fabiano Alves Gomes, Flavio Kapczinski. J Psychiatr Res 2011
244
9


Brain-derived neurotrophic factor and neuropsychiatric disorders.
Anita E Autry, Lisa M Monteggia. Pharmacol Rev 2012
676
9

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.
N Durany, T Michel, R Zöchling, K W Boissl, F F Cruz-Sánchez, P Riederer, J Thome. Schizophr Res 2001
259
9

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Elson Asevedo, Ary Gadelha, Cristiano Noto, Rodrigo B Mansur, André Zugman, Síntia I N Belangero, Arthur A Berberian, Bruno S Scarpato, Emilie Leclerc, Antônio L Teixeira,[...]. J Psychiatr Res 2013
60
15

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics.
Rodrigo W Grillo, Gustavo L Ottoni, Renata Leke, Diogo O Souza, Luiz V Portela, Diogo R Lara. J Psychiatr Res 2007
107
9

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.
C S Weickert, T M Hyde, B K Lipska, M M Herman, D R Weinberger, J E Kleinman. Mol Psychiatry 2003
355
9

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.
M Martinez-Cengotitabengoa, K S MacDowell, S Alberich, F J Diaz, B Garcia-Bueno, R Rodriguez-Jimenez, M Bioque, E Berrocoso, M Parellada, A Lobo,[...]. Schizophr Bull 2016
36
25

Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia.
Xiang Yang Zhang, Jun Liang, Da Chun Chen, Mei Hong Xiu, Fu De Yang, Therese A Kosten, Thomas R Kosten. Psychopharmacology (Berl) 2012
88
10


Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
Brian J Miller, Peter Buckley, Wesley Seabolt, Andrew Mellor, Brian Kirkpatrick. Biol Psychiatry 2011
912
8

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Yun Long Tan, Dong Feng Zhou, Lian Yuan Cao, Yi Zhuang Zou, Xiang Yang Zhang. Neurosci Lett 2005
103
8

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
Clarissa Severino Gama, Ana Cristina Andreazza, Maurício Kunz, Michael Berk, Paulo Silva Belmonte-de-Abreu, Flavio Kapczinski. Neurosci Lett 2007
109
8

Determinants of serum brain-derived neurotrophic factor.
B A A Bus, M L Molendijk, B J W H Penninx, J K Buitelaar, G Kenis, J Prickaerts, B M Elzinga, R C Oude Voshaar. Psychoneuroendocrinology 2011
185
8


Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Emmanouil N Rizos, Athanasia Papadopoulou, Efstathios Laskos, Panagiota G Michalopoulou, Anastasia Kastania, Dimitrios Vasilopoulos, Konstantinos Katsafouros, Lefteris Lykouras. World J Biol Psychiatry 2010
76
10


Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment.
Ah Hyun Lee, Claudia Lange, Roland Ricken, Rainer Hellweg, Undine E Lang. J Clin Psychopharmacol 2011
33
24


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.